Cheng, Anny M. S.
Tighe, Sean
Sheha, Hosam
Tseng, Scheffer C. G.
Funding for this research was provided by:
National Eye Institute (EY014768)
Article History
Received: 10 February 2017
Accepted: 14 September 2017
First Online: 3 November 2017
Compliance with ethical standards
:
: Dr. Tseng is the founder and a major shareholder of Tissue Tech Inc. that holds patents on the methods of preservation and clinical uses of amniotic membrane graft and PROKERA<sup>®</sup>. Other authors are employees of Tissue Tech.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from the patient in the study.